About Xeris
It's all about the experience. Everything we do is about simplifying and making things better and easier. It's about making a difference in people's lives.
Meet Xeris Pharmaceuticals
Xeris is a specialty pharmaceutical company leveraging novel formulation technology platforms to develop and commercialize ready-to-use, liquid-stable injectables.
Come see what we're aboutProducts
Our team is focused on creating medicines that are easier to use by leveraging our unique technology. Gvoke®(glucagon injection) leverages that technology to deliver ready-to-use solutions for patients and caregivers alike.
View our new offeringsTherapeutic Areas
Severe hypoglycemia and epilepsy are both conditions that can require rapid medical attention yet have complicated processes to administer treatment. We're ready to change that.
Discover how we can helpMedical Affairs
Supporting independent medical education, contributing to advancements in medical and scientific research, and supporting initiatives that enhance both patient experiences and the diabetes care community.
Learn MoreLeadership
We're people people. We've handpicked our team to ensure each individual's strengths further the pursuit of our shared goal to change patients' lives.
Get to know us
You have chosen a link to an external site.
By clicking "ok", a new window will open.
Do you wish to continue?
OK No Thanks!Not opening? Check to see you have pop-ups enabled or copy link below in a new window.
Xeris Biopharma is excited to announce approval for a new product, furthering our commitment to improving more patient's lives. Read More
Product Pipeline
Xeris has a robust pipeline of development programs to extend the current marketed products into important new indications and uses and bring new products forward using its proprietary formulation technology platforms.
Find out more
Approved Products
Gvoke® (glucagon injection)
Fact Sheet
Keveyis® (dichlorphenamide)
Fact Sheet
Recorlev® (levoketoconazole)
Fact Sheet